Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
1.330
-0.040 (-2.92%)
Jul 22, 2025, 3:56 PM HKT
HKG:2348 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 564.94 | 326 | 358.06 | 358.18 | 268.13 | Upgrade |
Depreciation & Amortization | 104.48 | 81.85 | 64.39 | 56.36 | 55.94 | Upgrade |
Other Amortization | 2.14 | 2.05 | 2.02 | 1.18 | 5.73 | Upgrade |
Loss (Gain) From Sale of Assets | 4.21 | 0.26 | -38.84 | -69.11 | 0.46 | Upgrade |
Loss (Gain) From Sale of Investments | -292.89 | -5.68 | -7.2 | -5.56 | -11.74 | Upgrade |
Loss (Gain) on Equity Investments | 3.7 | 40.93 | 61.91 | 46.42 | 18.77 | Upgrade |
Stock-Based Compensation | -0.51 | -1.02 | -4.91 | 4.33 | 8.11 | Upgrade |
Provision & Write-off of Bad Debts | -1.99 | 0.69 | 2.44 | - | - | Upgrade |
Other Operating Activities | 5.72 | -128.93 | 1.77 | -3.9 | -16.78 | Upgrade |
Change in Accounts Receivable | 40.73 | 73.38 | -79.82 | -27.07 | 40.25 | Upgrade |
Change in Inventory | -141.01 | 19.7 | -42.37 | 39.45 | -65.62 | Upgrade |
Change in Accounts Payable | 56.22 | -61.91 | 80.86 | -12.11 | 0.85 | Upgrade |
Change in Unearned Revenue | 3.36 | -0.3 | -0.3 | -0.3 | -0.3 | Upgrade |
Change in Other Net Operating Assets | -128.89 | -8.62 | 36.26 | 5.28 | -0.89 | Upgrade |
Operating Cash Flow | 220.2 | 338.4 | 434.27 | 393.14 | 302.9 | Upgrade |
Operating Cash Flow Growth | -34.93% | -22.07% | 10.46% | 29.79% | 9.81% | Upgrade |
Capital Expenditures | -126.04 | -199.55 | -204.37 | -313.07 | -139.1 | Upgrade |
Sale of Property, Plant & Equipment | 0.77 | 0.63 | 0.39 | 1.6 | 0.73 | Upgrade |
Cash Acquisitions | - | - | -8.64 | - | - | Upgrade |
Divestitures | - | - | 20.8 | 73.77 | - | Upgrade |
Sale (Purchase) of Intangibles | -49.58 | -12.46 | -21.3 | -89.96 | -65.2 | Upgrade |
Investment in Securities | 223.76 | -133.31 | -25.5 | 64.7 | 153.72 | Upgrade |
Other Investing Activities | 156.27 | -42.88 | 63.6 | -21.24 | 76.3 | Upgrade |
Investing Cash Flow | 205.17 | -387.57 | -175.01 | -284.2 | 26.45 | Upgrade |
Short-Term Debt Issued | 224.86 | 120.06 | 6.43 | 21.01 | - | Upgrade |
Total Debt Issued | 224.86 | 120.06 | 6.43 | 21.01 | - | Upgrade |
Short-Term Debt Repaid | -300 | - | - | - | -216.78 | Upgrade |
Long-Term Debt Repaid | -1.31 | -1.56 | -0.44 | -1.04 | -0.06 | Upgrade |
Total Debt Repaid | -301.31 | -1.56 | -0.44 | -1.04 | -216.84 | Upgrade |
Net Debt Issued (Repaid) | -76.45 | 118.51 | 6 | 19.97 | -216.84 | Upgrade |
Issuance of Common Stock | 1.37 | 1.17 | 0.35 | 2.19 | - | Upgrade |
Repurchase of Common Stock | - | - | - | -15.53 | -40.28 | Upgrade |
Common Dividends Paid | -111.2 | -117.08 | -99.54 | -143.91 | -81.61 | Upgrade |
Other Financing Activities | -3.16 | -0.53 | 0.5 | 7.53 | 11.03 | Upgrade |
Financing Cash Flow | -189.44 | 2.07 | -92.7 | -129.75 | -327.7 | Upgrade |
Foreign Exchange Rate Adjustments | 12.92 | 2.25 | 7.39 | 0.08 | -1.79 | Upgrade |
Net Cash Flow | 248.85 | -44.86 | 173.94 | -20.74 | -0.14 | Upgrade |
Free Cash Flow | 94.16 | 138.85 | 229.9 | 80.07 | 163.8 | Upgrade |
Free Cash Flow Growth | -32.19% | -39.61% | 187.12% | -51.12% | -32.32% | Upgrade |
Free Cash Flow Margin | 8.88% | 12.06% | 17.99% | 6.87% | 15.99% | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.09 | 0.15 | 0.05 | 0.11 | Upgrade |
Cash Interest Paid | 3.16 | 0.53 | - | 0.54 | 4.72 | Upgrade |
Cash Income Tax Paid | 76.74 | 62.52 | 63.19 | 65.16 | 67.66 | Upgrade |
Levered Free Cash Flow | -18.43 | -217.18 | 365.17 | -1.67 | 120.09 | Upgrade |
Unlevered Free Cash Flow | -16.17 | -216.56 | 365.4 | -1.27 | 123.11 | Upgrade |
Change in Net Working Capital | 72.94 | 259.91 | -267.63 | -101.91 | -57.32 | Upgrade |
Updated Sep 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.